Eli Lilly to lower insulin prices by 70% in US
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/15227620/hww0xk/ALTERNATES/schema-16_9/20200917-222409-4-7741x5164ma%2520(1).jpg)
US-based drugmaker Eli Lilly is planning to reduce list prices for its insulin products by 70% over the course of 2023.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Scientists discover flaw in insulin absorption assumption
For subscribers